From a regional pharmaceutical market in 1984 To a leading international pharmaceutical company, generating revenue of around L.E. 2.6 Billion in 2022.

MUP started as a small business in 1984 by launching 5 products.

Then the 1st conventional plant was established in Abu-Sultan (Ismailia), since then, MUP has grown significantly in Egypt, Middle East and Africa.

Over the last 3 decades, MUP has introduced 2 more factories; Penicillin & Cephalosporin in addition to acquiring Eli-Lilly’s insulin factory “Only insulin factory in middle east

Prof. Dr. Ahmed Lila Chairman & CEO ( 2022 - 2023 )

 2022-2023
 Start running L.V.P, S.V.P and Insulin Cartridge projects.
Launched Davalindi (vit. d3) new range; 5000 I.U., 10,000 I.U., 200,000 I.U. Ampoule. Dr. Awad Gabr
 Chairman & CEO ( 2019 - 2021 ) 2019
 Expansion of Warehouses capacity for APIs & Finished products
in Penicillin and Cephalosporin plants.
 2020-2021 Launched Silverburn. Dr. Ahmed Kelani
 Chairman & CEO ( 2016 - 2018 ) 2016-2017
 Launched Normifrin nasal spray.
 2018 Launched Spectracef, Fortazedim. Dr. Ahmed Kelani
 CEO ( 2013 - 2015 ) Dr. Mohamed Abd El-Gawad Chairman ( 2013 - 2015 ) 2013 Biological medicine era, Launched Insulinagypt. 2015 MUP became the First Egyptian company to acquire Eli-Lilly's Insulin factory in Egypt;
the only Insulin multinational facility in the MENA region. 2014 Cephalosporin and Penicillin factories started production, and since then,MUP joined the top leading
companies in antibiotics to become the “House of Antibiotics” in Egypt. Dr. Zakaria Gad Launched Streptoquin, Dispercam, GR6, Zinc Olive, Night & Day, Hi-Cal, Bebe-vit,
Vidrop, Laxolac and Mobitil. Chairman & CEO ( 1991 - 2011 ) Penicillin era, MUP launched blockbuster antibiotic Unictam.
Anti-Diabetic era, launched Dolcyl.
Cephalosporin era, launched Xorin. CVS era, launched Lipinorm & Irbedrin.
Started Cephalosporin and Penicillin new factories projects. 1991 - 2000 2001 - 2007 2008 - 2011 Dr. Salah Ramadan MUP was founded and the 1st conventional plant
in Abu Sultan – Ismailia-Egypt was established. 1989 - 1990 1984 - 1989 Launched stepping-stones; Ranitidine. Mucosol, Miconaz, Rifactine and Sorbit. Chairman & CEO ( 1984 - 1990 )
MUP history

Our History

1984 - 1990

Dr. Salah Ramadan

Chairman & CEO

1984 - 1989

MUP was founded and the 1st conventional plant in Abu Sultan – Ismailia-Egypt was established.

1989 - 1990

Launched stepping-stones; Ranitidine. Mucosol, Miconaz, Rifactine and Sorbit.

1991 - 2011

1991 - 2000

Launched Streptoquin, Dispercam, GR6, Zinc Olive, Night & Day, Hi-Cal, Bebe-vit, Vidrop, Laxolac and Mobitil.

Dr. Zakaria Gad

Chairman & CEO

2001 - 2007

Penicillin era, MUP launched blockbuster antibiotic Unictam.
Anti-Diabetic era, launched Dolcyl.
Cephalosporin era, launched Xorin.

2008 - 2011

CVS era, launched Lipinorm & Irbedrin.
Started Cephalosporin and Penicillin new factories projects.

2012 - 2016

Dr. Mohamed Abd El-Gawad

Chairman

Dr. Ahmed Kelani

CEO

2013

Cephalosporin and Penicillin factories started production, and since then, MUP joined the top leading companies in antibiotics to become the “House of Antibiotics” in Egypt.

2014

MUP became the First Egyptian company to acquire Eli-Lilly's Insulin factory in Egypt; the only Insulin multinational facility in the MENA region.

 

2015

Biological medicine era, Launched Insulinagypt.

2016 - 2018

Dr. Ahmed Kelani

Chairman & CEO

2016-2017

Launched Spectracef, Fortazedim.

 

2018

Launched Normifrin nasal spray.

2019 - 2022

Dr. Awad Gabr

Chairman & CEO

2019

Launched Silverburn.

 

2020

Expansion of Warehouses capacity for APIs & Finished products in Penicillin and Cephalosporin plants.

2022 - Present

Prof. Dr. Ahmed Lila

Chairman & CEO

2022

Start running L.V.P, S.V.P and Insulin Cartridge projects.
Launched Davalindi (vit. d3) new range; 5000 I.U., 10,000 I.U., 200,000 I.U. Ampoule.